Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Cash or invest? What Allied Farmers could do with $7m
Markets Small Cap Wrap

Cash or invest? What Allied Farmers could do with $7m

Plus, Promisia's insightful guidance, numerous AGMs, and more.

Heartland Group’s Q1 trading solid, not without challenges
Finance

Heartland Group’s Q1 trading solid, not without challenges

Heartland Group reports solid Q1 performance as NZ business conditions challenging.

Jarden analysts lower ratings on Air NZ, Michael Hill
Markets

Jarden analysts lower ratings on Air NZ, Michael Hill

Both companies cited ongoing economic challenges in their market updates.

Fonterra windfall brings risks: ASB
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct. 30